95 related articles for article (PubMed ID: 27608596)
1. T-3256336, a novel and orally available small molecule IAP antagonist, induced tumor cell death via induction of systemic TNF alpha production.
Sumi H; Inazuka M; Hashimoto K; Ishikawa T; Yoshida S; Yabuki M
Biochem Biophys Res Commun; 2016 Oct; 479(2):179-185. PubMed ID: 27608596
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity and pharmacodynamic biomarkers of a novel and orally available small-molecule antagonist of inhibitor of apoptosis proteins.
Sumi H; Yabuki M; Iwai K; Morimoto M; Hibino R; Inazuka M; Hashimoto K; Kosugi Y; Aoyama K; Yamamoto S; Yoshimatsu M; Yamasaki H; Tozawa R; Ishikawa T; Yoshida S
Mol Cancer Ther; 2013 Feb; 12(2):230-40. PubMed ID: 23243058
[TBL] [Abstract][Full Text] [Related]
3. An inhibitor of apoptosis protein antagonist T-3256336 potentiates the antitumor efficacy of the Nedd8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924).
Sumi H; Inazuka M; Morimoto M; Hibino R; Hashimoto K; Ishikawa T; Kuida K; Smith PG; Yoshida S; Yabuki M
Biochem Biophys Res Commun; 2016 Nov; 480(3):380-386. PubMed ID: 27771247
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.
Dai Y; Liu M; Tang W; DeSano J; Burstein E; Davis M; Pienta K; Lawrence T; Xu L
Clin Cancer Res; 2008 Dec; 14(23):7701-10. PubMed ID: 19047096
[TBL] [Abstract][Full Text] [Related]
5. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
[TBL] [Abstract][Full Text] [Related]
6. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
Roesler S; Eckhardt I; Wolf S; Fulda S
Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination profiling identifies sensitivity factors for IAP antagonist treatment.
Varfolomeev E; Izrael-Tomasevic A; Yu K; Bustos D; Goncharov T; Belmont LD; Masselot A; Bakalarski CE; Kirkpatrick DS; Vucic D
Biochem J; 2015 Feb; 466(1):45-54. PubMed ID: 25423073
[TBL] [Abstract][Full Text] [Related]
8. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
[TBL] [Abstract][Full Text] [Related]
9. Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro.
Sauer M; Reiners KS; Hansen HP; Engert A; Gasser S; von Strandmann EP
Biol Chem; 2013 Oct; 394(10):1325-31. PubMed ID: 23787466
[TBL] [Abstract][Full Text] [Related]
10. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.
Mitre-Aguilar IB; Barrios-Garcia T; Ruiz-Lopez VM; Cabrera-Quintero AJ; Mejia-Dominguez NR; Ventura-Gallegos JL; Moreno-Mitre D; Aranda-Gutierrez A; Mejia-Rangel J; Escalona-Guzman AR; Chavarri-Guerra Y; Leon-Del-Rio A; Zentella-Dehesa A
BMC Cancer; 2019 Apr; 19(1):356. PubMed ID: 30987626
[TBL] [Abstract][Full Text] [Related]
12. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
13. Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology.
Erickson RI; Tarrant J; Cain G; Lewin-Koh SC; Dybdal N; Wong H; Blackwood E; West K; Steigerwalt R; Mamounas M; Flygare JA; Amemiya K; Dambach D; Fairbrother WJ; Diaz D
Toxicol Sci; 2013 Jan; 131(1):247-58. PubMed ID: 22956632
[TBL] [Abstract][Full Text] [Related]
14. The cellular inhibitor of apoptosis protein-2 is a possible target of novel treatment for endometriosis.
Taniguchi F; Higaki H; Izawa M; Azuma Y; Hirakawa E; Deura I; Iwabe T; Hata K; Harada T
Am J Reprod Immunol; 2014 Mar; 71(3):278-85. PubMed ID: 24382102
[TBL] [Abstract][Full Text] [Related]
15. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
16. Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma.
McCabe KE; Bacos K; Lu D; Delaney JR; Axelrod J; Potter MD; Vamos M; Wong V; Cosford ND; Xiang R; Stupack DG
Cell Death Dis; 2014 Oct; 5(10):e1496. PubMed ID: 25356865
[TBL] [Abstract][Full Text] [Related]
17. Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.
Yuan Z; Syrkin G; Adem A; Geha R; Pastoriza J; Vrikshajanani C; Smith T; Quinn TJ; Alemu G; Cho H; Barrett CJ; Arap W; Pasqualini R; Libutti SK
Cancer Gene Ther; 2013 Jan; 20(1):46-56. PubMed ID: 23154431
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of apoptosis proteins as novel targets in inflammatory processes.
Mayer BA; Rehberg M; Erhardt A; Wolf A; Reichel CA; Kracht M; Krombach F; Tiegs G; Zahler S; Vollmar AM; Fürst R
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2240-50. PubMed ID: 21817100
[TBL] [Abstract][Full Text] [Related]
19. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner.
Stanculescu A; Bembinster LA; Borgen K; Bergamaschi A; Wiley E; Frasor J
Horm Cancer; 2010 Jun; 1(3):127-35. PubMed ID: 21152357
[TBL] [Abstract][Full Text] [Related]
20. IAP inhibitors enhance co-stimulation to promote tumor immunity.
Dougan M; Dougan S; Slisz J; Firestone B; Vanneman M; Draganov D; Goyal G; Li W; Neuberg D; Blumberg R; Hacohen N; Porter D; Zawel L; Dranoff G
J Exp Med; 2010 Sep; 207(10):2195-206. PubMed ID: 20837698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
